March 16, 2023

Embolx Enters International Distribution Agreement With Cardiva Italia

March 16, 2023—Embolx, Inc. announced the signing of a distribution agreement with Cardiva Italia SRL, adding to Embolx’s network of distribution partners across Europe. Embolx is a California-based, commercial-stage medical device company developing microcatheters for arterial embolization procedures to improve the treatment of various conditions, including cancerous tumors, benign prostatic hyperplasia, and uterine fibroids.

Cardiva Italia will distribute both the Embolx Sniper balloon occlusion microcatheter and the Soldier 2- and 2.5-F high-flow microcatheters, each in three lengths and two tip shapes, advised Embolx.

Michael Allen, President and CEO of Embolx, commented in the company’s press release, “We are extremely excited to partner with Cardiva Italia to expand our reach within the European market. Embolx and Cardiva Italia share the same goal to transform lives using innovative technology. That, combined with their skilled and experienced team, makes this partnership a no-brainer.”

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

March 16, 2023

Embolx Enters International Distribution Agreement With Cardiva Italia

Current Issue

Keep In Touch